baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

HSBC TUR.WAR.OP.END. BBZA/ DE000HG94HK4 /

8/2/2024 3:45:00 PM	Chg.-0.980	Bid5:19:52 PM	Ask5:19:52 PM	Underlying	Strike price	Expiration date	Option type
12.140EUR	-7.47%	- Bid Size: 10,000	- Ask Size: 10,000	BB BIOTECH N	29.9908 CHF	12/31/2078	Call

GlobeNewswire 4/2 Abivax reports 2023 financial results and operational update

GlobeNewswire 3/28 Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second ...

GlobeNewswire 11/27/2023 Arvinas Announces Oversubscribed $350 Million Private Placement

GlobeNewswire 3/8/2022 NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets

GlobeNewswire 6/17/2021 Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional ...

TeleTrader 4/15/2021 Incidence of blood clots in Pfizer, Moderna, AZ vaccines similar- report

TeleTrader 4/14/2021 EU to get 50M Pfizer COVID vaccines in Q2 rather than Q4

TeleTrader 11/11/2020 Pfizer, BioNTech grant EU 200 million vaccine doses

GlobeNewswire 12/16/2019 Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raise...

GlobeNewswire 10/19/2018 Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS,...

GlobeNewswire 1/2/2018 Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications

GlobeNewswire 12/6/2017 Non-Antibody Protein Scaffolds Drugs and Diagnostics Market, 2030

GlobeNewswire 10/19/2017 Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock

GlobeNewswire 12/2/2016 Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP...

GlobeNewswire 10/21/2016 Biotech stocks continue to advance

GlobeNewswire 10/11/2016 BB BIOTECH AG : BB Biotech AG with profit in the third quarter 2016

GlobeNewswire 10/11/2016 Ad hoc: BB Biotech AG with profit in the third quarter 2016

GlobeNewswire 7/29/2016 Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...

GlobeNewswire 7/22/2016 BB Biotech: Stabilization of biotech sector in the second quarter of 2016

GlobeNewswire 7/15/2016 BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...

GlobeNewswire 7/14/2016 BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...

GlobeNewswire 7/11/2016 BB Biotech AG with after-tax loss in the first half year of 2016

GlobeNewswire 6/23/2016 BB Biotech AG :Release of the Home Member State according to Article 2c of the WpHG (the German Secu...

GlobeNewswire 4/22/2016 BB BIOTECH AG: Challenging first quarter for biotech investments

GlobeNewswire 4/13/2016 BB Biotech AG with after-tax loss in the first quarter of 2016

HSBC TUR.WAR.OP.END. BBZA/ DE000HG94HK4 /

If you wish to receive reply to your feedback, please provide your email address.